Website Notice: We are still working out the bugs on our website. Please let us know if you spot any issues or experience any problems!
Clinical Overview

Understanding Neurofibromatosis

Neurofibromatosis is a group of distinct genetic conditions that cause tumors to form on nerve tissue throughout the central and peripheral nervous systems. Learn about its types, symptoms, and variable progression.

Genetic Classification

Classification of NF and Schwannomatosis

Under updated international consensus nomenclature, these conditions are recognized as NF1 and the schwannomatosis conditions, which include NF2-related schwannomatosis, SMARCB1-related schwannomatosis, LZTR1-related schwannomatosis, and other molecularly defined or currently unclassified forms.

NF1
🧬

Neurofibromatosis Type 1

Chromosome 17q11.2 | ~1 in 3,000 Births

The most common form of NF, caused by a pathogenic variant in the NF1 gene responsible for producing neurofibromin, an essential tumor suppressor protein.

  • •Multiple café-au-lait macules (light brown skin spots)
  • •Axillary and inguinal freckling (armpit and groin skinfolds)
  • •Cutaneous, subcutaneous, and plexiform neurofibromas
  • •Lisch nodules (iris hamartomas), choroidal abnormalities, and optic pathway gliomas
  • •Characteristic bone dysplasias including sphenoid wing dysplasia or anterolateral tibial bowing
NF2
🧠

NF2-Related Schwannomatosis

Chromosome 22q12.2 | ~1 in 25,000 to 40,000

Characterized by benign nerve tumors known as schwannomas, caused by pathogenic alterations in the NF2 gene producing the tumor suppressor merlin (schwannomin).

  • •Bilateral vestibular schwannomas along the eighth cranial nerve
  • •Progressive hearing loss, tinnitus, and balance disturbances
  • •Intracranial and spinal meningiomas, schwannomas, and ependymomas
  • •Juvenile posterior subcapsular cataracts and retinal hamartomas
SWN
🔬

Other Schwannomatosis Subtypes

SMARCB1, LZTR1, 22q & Unclassified Forms

Encompasses non-NF2 schwannomatosis conditions characterized by multiple non-intracranial schwannomas across peripheral and spinal nerves, frequently causing severe chronic pain.

  • •Multiple non-intracranial peripheral nerve schwannomas
  • •Intense localized or generalized neuropathic pain
  • •SMARCB1, LZTR1, 22q-related, and NOS/NEC variants
  • •Nerve numbness, tingling, and motor weakness
Disease Progression

Unpredictable Trajectories and Deferred Health Complications

One of the most challenging aspects of neurofibromatosis is that complications can be deferred across a person's lifespan. An individual may remain relatively symptom-free in childhood only to develop significant complications in adolescence or adulthood.

📈

Variable Expressivity & Age-Dependent Features

NF1 has very high, close to 100%, penetrance, with highly variable expressivity; the type and severity of manifestations can differ substantially even among affected members of the same family.

While pigmentary signs like café-au-lait spots and freckling often appear in infancy and early childhood, cutaneous neurofibromas, plexiform growth, optic pathway changes, or spinal schwannomas frequently emerge or progress later during puberty, pregnancy, or mid-adulthood.

🫁

Internal & Secondary Complications

Internal plexiform neurofibromas can wrap around deep nerve plexuses and internal organs, remaining silent until their volume creates compressive neuropathy, chronic pain, or airway and gastrointestinal impairment.

Because some plexiform neurofibromas can undergo malignant transformation (MPNST), people with NF1 should receive appropriate clinical surveillance and promptly report concerning changes such as persistent or rapidly worsening pain, rapid tumor growth, new weakness, or other neurological changes. Imaging is used when clinically indicated and for surveillance of known tumors as recommended by specialists.

⚡

Physical Health Complications, Organ Damage & Medical Realities

Rare in the general population, but common or elevated in individuals with neurofibromatosis.

🩻

Regular MRI Cancer Surveillance & Malignant Transformation (MPNST)

Lifelong necessity for regular whole-body and targeted MRI imaging to screen for Malignant Peripheral Nerve Sheath Tumors (MPNST), an aggressive soft-tissue sarcoma with markedly heightened incidence in NF1.

⚡

Peripheral Nerve Ending Damage & Neuropathic Pain

Tumors growing directly within and along nerve sheaths, damaging and compressing peripheral nerve endings to trigger intractable burning pain, electric-shock sensations, numbness, paresthesias, and motor weakness.

🧠

Damage to the Brain & Central Nervous System

Optic pathway gliomas threatening vision or causing complete blindness; brainstem gliomas; bilateral vestibular schwannomas along cranial nerve VIII causing sensorineural deafness and vestibular dysfunction in NF2; and aqueductal stenosis causing hydrocephalus.

🫁

Compression & Damage to Vital Structures and Organs

Massive plexiform neurofibromas eroding into the spinal canal (leading to spinal cord compression, myelopathy, and irreversible paralysis), encircling the trachea (airway obstruction), or invading the gastrointestinal and pelvic viscera.

🫀

Circulatory Pressure & Vascular Damage

Vascular dysplasias putting severe pressure on whole-body blood circulation, including renal artery stenosis causing refractory severe hypertension, Moyamoya syndrome (cerebral arterial occlusion increasing ischemic stroke risk), and arterial aneurysms.

🦴

Severe Skeletal Deformities & Bone Dysplasias

Rapidly progressive dystrophic scoliosis requiring spinal instrumentation, tibial pseudoarthrosis (congenital non-healing bone fractures), sphenoid wing dysplasia (erosion of the orbital bone around the eye), and generalized osteopenia.

⚠️

Endocrine & Adrenal Tumors (Pheochromocytoma)

Rare, life-threatening adrenal medullary tumors (pheochromocytomas) that hypersecrete adrenaline, provoking sudden hypertensive crises, cardiac arrhythmias, severe headaches, and panic-like spikes.

🔬

Gastrointestinal & Internal Tumors

Gastrointestinal Stromal Tumors (GIST) resulting in occult internal gastrointestinal hemorrhage, severe bowel obstruction, and chronic pain, alongside exquisitely tender glomus tumors under the nail beds.

🧠

Common Mental Health & Psychosocial Challenges

Documented in peer-reviewed medical and psychiatric literature for people living with NF.

🏥

"Scanxiety" & Anticipatory Medical Panic

Intense anticipatory fear, insomnia, and acute emotional distress in the days and weeks leading up to routine MRI cancer screening scans and waiting for radiology results.

🌪️

Clinical Anxiety & Generalized Anxiety Disorder (GAD)

Elevated baseline anxiety driven by unpredictable tumor trajectories, sudden health changes, and lifelong illness uncertainty.

🌧️

Depression & Major Depressive Episodes

Clinical depression secondary to intractable chronic neuropathic pain, functional physical losses, societal stigma, and systemic fatigue.

🧩

ADHD & Executive Functioning Challenges

Children and adolescents with NF1 may experience challenges with working memory, processing speed, impulse control, and organizational skills.

🔋

Cognitive Fatigue & "Brain Fog"

Persistent neural exhaustion caused by continuous pain signal processing, central neural compensation, and sensory overload.

🪞

Body Image Distress & Social Anxiety

Self-consciousness, social withdrawal, and body dysmorphic distress resulting from visible cutaneous neurofibromas, plexiform facial/limb changes, or extensive surgical scarring.

🌙

Sleep Architecture Disruption & Insomnia

Severe sleep disruption stemming from nocturnal nerve compression, burning pain flares, and somatic anxiety.

🍂

Chronic Sorrow & Adjustment Grief

Recurring cycles of psychological grief as individuals adjust to new physical impairments, career limitations, or loss of physical independence.

🩺

The Critical Role of Lifelong Multidisciplinary Surveillance

Because complications can arise unpredictably, standard care involves regular assessments with geneticists, neurologists, neuro-oncologists, ophthalmologists, orthopedic surgeons, and dermatologists. Catching changes early enables modern targeted interventions, pain management, and surgical planning.

Clinical Assessment

Diagnostic Criteria and Genetic Testing

NF1 diagnosis is based on internationally revised diagnostic criteria published in 2021. In an individual without an affected parent, diagnosis generally requires two or more qualifying features, which can include café-au-lait macules, axillary or inguinal freckling, neurofibromas or a plexiform neurofibroma, optic pathway glioma, Lisch nodules or choroidal abnormalities, characteristic osseous lesions, or a heterozygous pathogenic NF1 variant. Different criteria apply when a parent meets diagnostic criteria for NF1.

Comprehensive next-generation genetic sequencing can confirm pathogenic variants in NF1, NF2, SMARCB1, and LZTR1. Genetic testing is particularly valuable for young children exhibiting isolated features or for individuals with suspected mosaic/segmental NF.

📜

Direct Consensus Publication

Legius E, et al. "Revised diagnostic criteria for neurofibromatosis type 1 and Schwannomatosis: an international consensus recommendation." Genet Med. 2021;23(8):1506-1513.

📋

Key Diagnostic Takeaways

  • ✓NF is genetic, but roughly 50% of cases arise from spontaneous new mutations with no prior family history.
  • ✓Health complications vary widely and require individualized medical monitoring across every stage of life.
  • ✓Dedicated NF centers coordinate multi-specialty care to address neurological, orthopedic, and dermatological needs.

Have Questions or Seeking Guidance?

Ken of the Rocky Mountains LLC is committed to providing reliable information, specialist navigation support, and custom awareness apparel.